The Competent Function of Granulosa Cells During Ppos in Normalovulatory Women Undergoing Ivf/Icsi Treatments.
L. Zhou,Y. Kuang,W. Chai
DOI: https://doi.org/10.1016/j.fertnstert.2016.07.570
IF: 6.7
2016-01-01
Fertility and Sterility
Abstract:ObjectiveOur previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol.DesignA translational research study.Materials and MethodsHuman granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence.ResultsThe cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05).ConclusionsTabled 1Cycle characteristics and outcomes.Agonist group (N=50)HMG+MPA (N=68 )Age(y)32.3±3.731.3±3.7Body mass index(kg/m2)21.4±2.220.9±2.4Antral follicle count(n)10.0±4.511.2±3.4b FSH(IU/L)5.6±1.35.7±1.2hMG dose(IU)1489.5±45.8a1865.1±304.4bOocytes retrieved(n)11.0±6.2a13.7±6.3bMIIoocyte(n)9.3±5.8a12.1±5.6bFertilized oocytes(n)7.5±4.5a9.4±4.9bTop-quality embryos(n)3.2±3.6a4.8±3.6bCancellation rate(%)20.0(10/50)a5.8(4/68)bClinical pregnancy rate per transfer(%)0.3(4/16)0.4(21/51) Open table in a new tab References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70. ObjectiveOur previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol. Our previous study demonstrated that medroxyprogesterone acetate (MPA) is an effective oral alternative for the prevention of premature LH surge in normalovulatory woman undergoing controlled ovarian hyperstimulation (COH), and the pregnancy outcomes from FET indicated that the embryos originating from PPOS had similar developmental potential as the short protocol(1). In this study,we investigate the expression related to gonadotropin receptors, sex hormone receptors and steroidogenesis in granulosa cells of normalovulatory women undergoing IVF/ICSI treatments with hMG and MPA protocol. DesignA translational research study. A translational research study. Materials and MethodsHuman granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence. Human granulosa cells (GCs) retrieved from the patients undergoing agonist group and hMG+MPA group were quantitatively compared with qPCR and western blot for the expression of steroidogenic enzymes (stAR, Scc, HSD3B2, aromatase), gonadotropin receptors (FSHR, LHR) and sex hormone receptors (PR, ER). Serum E2 on the trigger day was measured with chemiluminescence. ResultsThe cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05). The cycle characteristics and outcomes show in table. The expression of FSHR and PR, at both the mRNA and protein levels, were significantly higher in hMG+MPA group than agonist group .While the expression of steroidogenic enzymes were similar between the two groups. The serum E2 level on the trigger day in the two groups was 3811.9 pg/ml, 3836.4 pg/ml, respectively, with no statistic significance (p>0.05). ConclusionsTabled 1Cycle characteristics and outcomes.Agonist group (N=50)HMG+MPA (N=68 )Age(y)32.3±3.731.3±3.7Body mass index(kg/m2)21.4±2.220.9±2.4Antral follicle count(n)10.0±4.511.2±3.4b FSH(IU/L)5.6±1.35.7±1.2hMG dose(IU)1489.5±45.8a1865.1±304.4bOocytes retrieved(n)11.0±6.2a13.7±6.3bMIIoocyte(n)9.3±5.8a12.1±5.6bFertilized oocytes(n)7.5±4.5a9.4±4.9bTop-quality embryos(n)3.2±3.6a4.8±3.6bCancellation rate(%)20.0(10/50)a5.8(4/68)bClinical pregnancy rate per transfer(%)0.3(4/16)0.4(21/51) Open table in a new tab References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70. References:1.Kuang YP, Chen QJ, Fu YL,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing contolled ovatian huperstimulation for in vitro fetilization. Fertil Steril. 2015;104:62-70.